Cell Line Development (Equipment, Media and Reagents) Market - Analysis & Global Forecast to 2019

DUBLIN, Oct. 2, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Cell Line Development Market by Product, Source, Type & by Application - Analysis & Global Forecast to 2019" report to their offering.

Over the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have led to growth in a number of applications of cell lines such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery.

Cell line development media and reagents account for the largest share in the global cell line development market, as they have numerous applications in areas such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. The reagents segment accounted for the maximum share of the cell line development media and reagents market. The bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and in manufacturing of recombinant protein therapeutics.

North America accounted for the largest share of the global cell line development market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cell line development market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to serve as revenue pockets for cell line manufacturers.

The global cell line development market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

The cell line development market is highly competitive with a large number of players, including both big and small players, operating in this market. Cell lines are used in many pharmaceutical and biotechnology industries, academic research institutes, and diagnostic laboratories. In order to develop high-yielding and stable cell lines, companies and research institutes are engaged in research activities to develop more efficient technologies for development of cell lines.

The global market is segmented on the basis of product, source, type, application, and geography. The global market, by product is categorized into equipment and media and reagents. The media and reagents segment is further divided into serum, media, and reagents. The reagents market is expected to account for the largest share of the market. However, media is expected to be the fastest-growing segment in the reagents market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global Cell Line Development Market, By Product

8 Cell Line Development Market, By Source

9 Cell Line Development Market, By Type

10 Global Cell Line Development Market, By Application

11 Cell Line Development Market, By Geography

12 Competitive Landscape

13 Company Profiles

Companies Mentioned:

• American Type Culture Collection (ATCC)
• Corning, Inc.
• European Collection of Cell Cultures (ECACC)
• GE Healthcare
• Lonza Group AG
• Sartorius AG
• Selexis SA
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific, Inc.
• Wuxi Apptec

For more information visit http://www.researchandmarkets.com/research/vhb3pb/cell_line

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets